版本:
中国

BRIEF-Neovasc says receives regulatory approval to initiate Tiara II ce mark study

Nov 28 Neovasc Inc :

* Says receives regulatory approval to initiate Tiara II ce mark study

* Says expects first Italian tiara ii clinical study site will be initiated before year end

* Says approvals in additional geographies are expected in Q1 of 2017

* Says expected that data from the study will be used to file for ce mark approval for Tiara Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐